SENORES · Senores Pharmaceuticals Limited · Financials
Market Cap
54.09B INR
Shares
46.05M
Volume · Nov 13
409.5K
Avg daily vol (3M)
277.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
6.33B
+58.9%
FY2026
Net Income
0
-100%
FY2026
Operating Cash Flow
620.5M
+235.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 7.22B | 6.33B | 3.98B |
| INR | 373.4M | 312.5M | 168.4M |
| INR | 297.3M | 250.3M | 215.5M |
| INR | 1.79B | 1.59B | 705.7M |
| INR | 417.4M | 375.7M | 122.3M |
| INR | 1.02B | 0 | 583.4M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.